Abstract
Background
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal malignancy of the gastrointestinal tract. At present, it is generally believed that the prognosis of GIST is closely related to its risk classification. It may add value to correctly diagnose and evaluate the risk of invasion using a noninvasive imaging examination prior to surgery. MRI has the advantages of multiple parameters and high soft tissue resolution, which may be the potential method to preoperatively evaluate the risk of GIST.
Purpose
To retrospectively evaluate the diagnostic accuracy of multi-parameter MR analysis for preoperative risk classification of GIST.
Materials and methods
In this 6-year retrospective study, full MRI examination was performed on all 60 GIST cases confirmed classified by pathology, including 35 cases of very low-to-low-risk GIST and 25 cases of intermediate-to-high-risk GIST. Dynamic contrast-enhanced T1- and T2-weighted images, and apparent diffusion coefficient (ADC) maps were reviewed independently by two radiologists blinded to pathologic results. Volume, ADC ratio, three wash-in indexes (WII) were calculated and compared using t-test or Kruskal–Wallis nonparametric test. Sensitivity and specificity analyses were performed to calculate diagnostic accuracy using ROC analyses. Differences were considered significant at p < 0.05.
Results
All GISTs were resected. Patient age, sex, tumor location and tumor shape did not differ significantly across the two groups (p = 0.798, 0.767, 0.822 and 0.096, respectively). GIST in the intermediate-to-high-risk group presented significantly greater volume (p = 0.0045), lower ADC ratio (p = 0.0125) and faster enhancement (for WII2, p < 0.0001; for WII3, p = 0.0358) than that of GIST in the very low-to-low-risk group. This combination of the volume, ADC ratio and WII2 provided sensitivity of 88%, specificity of 94.29%, and accuracy of 91.7% for the risk classification of GIST.
Conclusion
Multi-parameter MR analysis provides a preoperative imaging standard for accurately distinguishing very low-to-low-risk GIST from intermediate-to-high-risk GIST.
Similar content being viewed by others
References
Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM (1998) Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152(5):1259–1269
Kisluk J, Zinczuk J, Kemona A, et al. (2016) Expression of CD117, DOG-1, and IGF-1R in gastrointestinal stromal tumours - an analysis of 70 cases from 2004 to 2010. Prz Gastroenterol 11(2):115–122
Fletcher CD, Berman JJ, Corless C, et al. (2002) Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33(5):459–465
Joensuu H (2008) Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 39(10):1411–1419
von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2018;16(5):536-63.
Mazzei MA, Cioffi Squitieri N, Vindigni C, et al. (2020) Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy. Abdom Radiol (NY) 45(10):2989–2996
Hou YY, Grabellus F, Weber F, et al. (2009) Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection. J Gastrointest Surg 13(9):1583–1592
Caterino S, Lorenzon L, Petrucciani N, et al. (2011) Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol 9:13
Sicklick JK, Lopez NE (2013) Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors. J Gastrointest Surg 17(11):1997–2006
Dimitrakopoulou-Strauss A, Ronellenfitsch U, Cheng C, et al. (2017) Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review. Clin Transl Imaging 5(3):183–197
Yin SH, Xie CM, Mo YX, et al. (2009) Correlation of multi-slice spiral CT features to clinicopathologic manifestations of gastrointestinal stromal tumor: a report of 49 cases. Ai Zheng 28(9):983–988
Kim H, Keene KS, Sarver DB, et al. (2014) Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: a pilot study. Gastrointest Cancer Res 7(3–4):75–81
Zhou HY, Zhang XM, Zeng NL, Jian SH, Tang W (2012) Use of conventional MR imaging and diffusion-weighted imaging for evaluating the risk grade of gastrointestinal stromal tumors. J Magn Reson Imaging 36(6):1395–1401
Chamadol N, Laopaiboon V, Promsorn J, et al. (2009) Gastrointestinal stromal tumor: computed tomographic features. J Med Assoc Thai 92(9):1213–1219
Da Ronch T, Modesto A, Bazzocchi M (2006) Gastrointestinal stromal tumour: spiral computed tomography features and pathologic correlation. Radiol Med 111(5):661–673
Yu MH, Lee JM, Baek JH, Han JK, Choi BI (2014) MRI features of gastrointestinal stromal tumors. AJR Am J Roentgenol 203(5):980–991
Cornelis F, Tricaud E, Lasserre AS, et al. (2014) Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol 24(5):1068–1080
Yamamoto H, Oda Y (2015) Gastrointestinal stromal tumor: Recent advances in pathology and genetics. Pathology International 65(1):9–18
Guo C, Zhuge X, Chen X, et al. (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors. Oncol Lett 13(6):4141–4146
Pinaikul S, Woodtichartpreecha P, Kanngurn S, Leelakiatpaiboon S (2014) Gastrointestinal stromal tumor (GIST): computed tomographic features and correlation of CT findings with histologic grade. J Med Assoc Thai 97(11):1189–1198
Cui, Feng, Fangfang, Lu, Yaqi, Shen, et al. Tumor heterogeneity in gastrointestinal stromal tumors of the small bowel: volumetric CT texture analysis as a potential biomarker for risk stratification. Cancer Imaging the Official Publication of the International Cancer Imaging Society 2018;18:46-53.
Tateishi U, Hasegawa T, Satake M, Moriyama N. Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality. J Comput Assist Tomogr 2003;27(5):792-8.
Amano M, Okuda T, Amano Y, Tajiri T, Kumazaki T (2006) Magnetic resonance imaging of gastrointestinal stromal tumor in the abdomen and pelvis. Clin Imaging 30(2):127–131
Rezai P, Pisaneschi MJ, Feng C, Yaghmai V (2013) A radiologist’s guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers. AJR Am J Roentgenol 201(2):237–245
Miyake K, Kawaguchi K, Kiyuna T, et al. (2018) Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model. Cell Cycle 17(6):722–727
Chen T, Liu S, Li Y, et al. (2019) Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning. EBioMedicine 39:272–279
Maldonado FJ, Sheedy SP, Iyer VR, et al. (2018) Reproducible imaging features of biologically aggressive gastrointestinal stromal tumors of the small bowel. Abdom Radiol (NY) 43(7):1567–1574
Gong J, Kang W, Zhu J, Xu J (2012) CT and MR imaging of gastrointestinal stromal tumor of stomach: a pictorial review. Quant Imaging Med Surg 2(4):274–279
Sotak CH (2004) Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int 45(4):569–582
Mizukami Y, Ueda S, Mizumoto A, et al. (2011) Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg 35(4):895–899
Yamamura J, Salomon G, Buchert R, et al. (2011) Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomogr 35(2):223–228
Tang H, Ahlawat S, Fayad LM (2018) Multiparametric MR Imaging of Benign and Malignant Bone Lesions. Magn Reson Imaging Clin N Am 26(4):559–569
Duvnjak P, Schulman AA, Holtz JN, et al. (2018) Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making. The Urologic clinics of North America 45(3):455–466
Parab TM, DeRogatis MJ, Boaz AM, et al. (2019) Gastrointestinal stromal tumors: a comprehensive review. Journal of gastrointestinal oncology 10(1):144–154
Akahoshi K, Oya M, Koga T, Shiratsuchi Y (2018) Current clinical management of gastrointestinal stromal tumor. World journal of gastroenterology 24(26):2806–2817
Acknowledgements
This research was supported by National Natural Science Foundation of China (81871029) and Scientific Research Fund Project of Health Commission of Hebei Province (20200138).
Author information
Authors and Affiliations
Contributions
TZ and LL designed and coordinated the study, TZ, JD, SW, ZW, DL, XW and QS carried out experiment and data process, and drafted the manuscript. All authors gave final approval for publication.
Corresponding author
Ethics declarations
Conflict of interest
Author Qinglei Shi was employed by the company Siemens Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Research involving human participants
This retrospective study involved human participants. This retrospective study that incorporates anonymous data was approved by the Ethics Committee of our hospital and the need for informed consent was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zheng, T., Du, J., Yang, L. et al. Evaluation of risk classifications for gastrointestinal stromal tumor using multi-parameter Magnetic Resonance analysis. Abdom Radiol 46, 1506–1518 (2021). https://doi.org/10.1007/s00261-020-02813-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02813-y